Stockreport

Wells Fargo Reaffirms a Buy Rating on Nurix Therapeutics (NRIX), Sets a $30 PT [Yahoo! Finance]

Nurix Therapeutics, Inc. - Common stock  (NRIX) 
PDF Derek Archila reaffirmed a Buy rating on Nurix Therapeutics, Inc. (NASDAQ:NRIX) with a $30 price target. In a separate development, Nurix Therapeutics, Inc. (NASDAQ:NR [Read more]